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CYFIP/Sra-1 Controls Neuronal Connectivity
in Drosophila and Links the Rac1
GTPase Pathway to the Fragile X Protein
the postsynaptic site of most excitatory synapses in
mammalian brains (for review see Luo, 2002).
Fragile X syndrome, the most frequent cause of hered-
itary mental retardation, is caused by the absence of
the RNA binding protein FMRP (for review see Bardoni
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et al., 2001). FMRP is present at synapses and can actInstitut de Ge´ne´tique et de Biologie
as a translational regulator (Weiler et al., 1997; Lagger-Mole´culaire et Cellulaire
bauer et al., 2001; Li et al., 2001; Brown et al., 2001;CNRS/INSERM/ULP, Boite Postale 10142
Miyashiro et al., 2003; Zalfa et al., 2003). It binds to67404 Illkirch Cedex
specific mRNAs through an RNA G quartet structureFrance
(Schaeffer et al., 2001; Darnell et al., 2001), and its Dro-3 Department of Molecular Biology
sophila ortholog, dFMR1, has been recently found toand Biochemistry
associate with the RNAi silencing machinery (IshizukaSimon Fraser University
et al., 2002; Caudy et al., 2002). Misregulation of target8888 University Drive
mRNAs may account for the abnormal maturation ofBurnaby, British Columbia, V5A 1S6
dendritic spines that has been observed in brains ofCanada
fragile X patients and in knockout mice (Comery et al.,
1997; Irwin et al., 2000; Nimchinsky et al., 2001).
Whether and how the molecular pathways controlling
Summary translation and cytoskeleton remodeling are connected
is not yet understood. Our approach to identify FMRP
Neuronal plasticity requires actin cytoskeleton remod- interacting proteins (Bardoni et al., 1999) has recently
eling and local protein translation in response to extra- led to the characterization of the human cytoplasmic
cellular signals. Rho GTPase pathways control actin FMRP interacting proteins CYFIP1 and CYFIP2, which
reorganization, while the fragile X mental retardation are 88% identical in their amino acid sequence (Schenck
protein (FMRP) regulates the synthesis of specific pro- et al., 2001). CYFIP1, also known as Sra-1, had been
teins. Mutations affecting either pathway produce previously described as an interactor of Rac1 (Koba-
neuronal connectivity defects in model organisms and yashi et al., 1998), a Rho GTPase family member. Hence,
mental retardation in humans. We show that CYFIP, the identification of the CYFIP1 and CYFIP2 suggested
the fly ortholog of vertebrate FMRP interactors CYFIP1 a direct connection between signaling pathways con-
and CYFIP2, is specifically expressed in the nervous trolling neuronal plasticity and cognition.
system. CYFIP mutations affect axons and synapses, The Drosophila genome contains a single ortholog of
much like mutations in dFMR1 (the Drosophila FMR1 the human FXR gene family (coding for FMRP and its
ortholog) and in Rho GTPase dRac1. CYFIP interacts related proteins FXR1P and FXR2P): dFMR1 (also called
biochemically and genetically with dFMR1 and dRac1. dFXR). dFMR1’s biochemical properties and role seem
Finally, CYFIP acts as a dRac1 effector that antago- conserved in the fly nervous system (Wan et al., 2000;
nizes FMR1 function, providing a bridge between sig- Zhang et al., 2001; Morales et al., 2002; Dockendorff et
nal-dependent cytoskeleton remodeling and trans- al., 2002; Schenck et al., 2002). A single fly CYFIP gene
lation. (Schenck et al., 2001) is similarly related to human
CYFIP1 and CYFIP2 (67% identity at the protein level).
Finally, the GTPase dRac1 has been extensively studied
Introduction
in flies. The existence of single FXR and CYFIP orthologs
as well as the evolutionary functional conservation
Understanding the molecular mechanisms involved in makes the fly an ideal model to elucidate their role in
neuronal wiring and in activity-dependent plasticity is neuronal morphogenesis and plasticity in vivo.
one of the most important topics of modern neurobiol- We show here that Drosophila CYFIP/Sra-1, which we
ogy, since these processes control cognitive functions. will refer to as “CYFIP” throughout the text, is highly
Analysis of model organisms and genes mutated in expressed in neurons, where it accumulates in central
cases of inherited mental retardation has identified two axons and at motor neuron terminals. CYFIP mutations
types of molecules important for such processes, the are lethal and induce defects in axon growth, branching,
fragile X mental retardation protein (FMRP) and Rho and pathfinding. The overall organization of the neuro-
GTPases (reviewed in Bardoni and Mandel, 2002; Ra- muscular junction (NMJ) is also significantly affected.
makers, 2002; Chelly and Mandel, 2001). Rho GTPase Loss of CYFIP therefore involves defects that have been
pathways remodel actin cytoskeleton in response to previously described in dFMR1 and/or dRac1 mutants
extracellular stimuli (Hall, 1998). In neurons, they regu- (Morales et al., 2002; Dockendorff et al., 2002; Luo et
late axon and dendrite outgrowth as well as develop- al., 1994; Hakeda-Suzuki et al., 2002). We provide evi-
ment, maturation, and maintenance of dendritic spines, dence for CYFIP-dFMR1 and CYFIP-dRac1 biochemical
interactions. Finally, dosage-dependent experiments re-
veal genetic interactions in vivo. These latter experi-*Correspondence: angela@titus.u-strasbg.fr (A.G.), bardoni@titus.
u-strasbg.fr (B.B.) ments allow us to order the three molecules within a
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Figure 1. CYFIP Profile of Expression
(A) Northern blot analysis throughout devel-
opment. Lanes correspond to poly(A) RNA
isolated from pooled embryonic (embryos) or
larval (L1–L3) stages, from wandering larvae
(WL), pupae, adult males or females. “ov” in-
dicates mRNA isolated from dissected adult
ovaries. The same blot was probed with a
loading control (rp49, lower panel).
(B) In situ hybridization on whole-mount em-
bryos, anterior to the left. CYFIP mRNA is
uniformly distributed at early embryonic
stages (stage 5) and predominantly ex-
pressed in the central nervous system (CNS)
at stage 17 (dorsal view). br, brain; vnc, ven-
tral nerve cord.
(C) Western blot analysis of Drosophila S2
cell line extract using anti-CYFIP.
(D) Western blot analysis of staged embryos.
Equivalent amounts of protein extracts were
loaded. Embryonic stages are indicated at
the top as hours after egg laying at 25C.
(E and F) CYFIP immunolabeling of whole-
mount embryos at stage 13 and 16, respec-
tively, ventral views. (E) CNS (arrows), midline
(arrowheads), and gut (g) labeling. (F) CYFIP
strongly accumulates in CNS axons. Moder-
ate labeling is also present in some peripheral
structures.
(G–I) Stage 17 embryo double labeled with
anti-Fas II (green) and anti-CYFIP (red) to vi-
sualize axon terminals of intersegmental mo-
tor nerve b (ISNb) at the muscle 6/7 junction
(arrowheads). Dorsal is up, anterior to the left.
Pictures represent projections of three confo-
cal sections at the focal plane of the muscle
6/7 junction.
(J) Schematic representation of lateral mus-
cles and innervation pattern by ISNb.
Scale bars, 50 m (B, E, and F), 5 m (G–J).
pathway that regulates neuronal morphology and con- as development proceeds, CNS labeling persists and
increases in intensity until the end of embryogenesisnectivity.
(data not shown and Figure 1B). In addition, CYFIP is
expressed at low levels throughout the embryo.Results
Cloning of CYFIP and Expression Profile CYFIP Strongly Accumulates in Axons of the CNS
In order to characterize the CYFIP protein, we developedthroughout Development
A full-length Drosophila CYFIP cDNA (accession number an anti-CYFIP antibody, which detects a single band of
145 kD in Western blot analysis on Drosophila SchneiderAY017343; Schenck et al., 2001) was obtained by using
two overlapping EST clones. To assess at which stage (S2) cell and embryonic extracts (Figures 1C and 1D).
The size of the recognized protein corresponds to theCYFIP is expressed, we performed Northern blot analy-
sis on poly(A) RNA from embryos, larvae, wandering predicted molecular weight (Schenck et al., 2001). To
confirm that this band corresponds to CYFIP, we tran-larvae, pupae, and adults. CYFIP is present throughout
the fly life cycle as a single transcript of around 4.5 kb siently overexpressed the full-length product in S2 cells;
extracts of transfected cells contain higher levels ofand is also abundant in adult ovaries (Figure 1A). Signal
quantification and normalization against a loading con- the 145 kD product than nontransfected cells (data not
shown).trol indicated that there are no major peaks of CYFIP
expression at specific stages (Figure 1A). In situ hybrid- The CYFIP embryonic profile follows that of the tran-
script. It is detectable by stage 11 in the CNS, by stageization revealed that CYFIP is ubiquitously and highly
expressed in embryos at precellular (data not shown) 13 in the gut (Figure 1E). Its levels in the CNS increase
until the end of embryogenesis (Figure 1F). CYFIP isand cellular blastoderm stages (Figure 1B, stage 5).
Starting from stage 12, CYFIP labeling is mostly de- a cytoplasmic protein—like its human orthologs—that
specifically accumulates in CNS axons, along commis-tected in the developing central nervous system (CNS)
and in the gut. While CYFIP labeling in the gut diminishes sures and longitudinal connectives. Some CYFIP ex-
CYFIP Links dFMR1 and dRac1 in Neuronal Wiring
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Figure 2. CYFIP Locus and Mutants
(A) Organization of the genomic CYFIP locus. The CYFIP gene is composed of nine coding exons. “EP” indicates the transposon insertion in
EP line (3)3267, and “UAS” indicates the upstream activating sequence contained in the transposon. For both CYFIP and CG6226, the exon/
intron organization is shown. “ATG” and “1” indicate the predicted translation and transcription initiation sites, respectively. “Stop” indicates
the end of the predicted open reading frame.
(B) Molecular lesions of some excision mutants.
(C) CYFIP and CG6226 in situ hybridization data on homozygous mutant embryos. The mutant line is indicated in the left column, the utilized
probe as well as the viability percentage of homozygous adults in the top row.
pression is detected at the midline (Figures 1E and 1F, dylisomerase, for which no mutant strain is reported.
To assess whether CYFIP mutants also affect CG6226arrowheads). Finally, CYFIP also accumulates at the mo-
tor axon terminals, at the stage at which synaptogenesis expression, we performed in situ hybridization using
CYFIP- and CG6226-specific probes on wt, EP(3)3267,is initiated. Double labeling with an antibody (anti-Fas
II) recognizing synapses (Schuster et al., 1996) revealed and excision lines CYFIP5.2, CYFIP8.1, CYFIP85.1, and
CYFIP70.1 (Figure 2C). While CYFIP5.2 is null for both genesthat CYFIP is localized at the NMJ (Figures 1G–1J).
Western blot analysis (Figure 1D) shows that CYFIP (data not shown), lines CYFIP8.1 and CYFIP85.1 only affect
CYFIP. Lack of CYFIP mRNA in CYFIP8.1 (EP internalis already present at early embroynic stages (0–3 hr,
corresponding to stages 1–6 [according to Campos- deletion) is likely due to altered stability of the modified
transcript. Line CYFIP85.1, in which about two-thirds ofOrtega and Hartenstein 1985]), even though its levels
are much lower than at later stages (6–18 hr, [stage the CYFIP coding region are deleted, was further used
to characterize the CYFIP null mutant phenotype (Figure12–17]).
2B) (for loss of CYFIP immunoreactivity in this line, see
also Figures 5A and 5B).Generation of CYFIP Null Mutants
The prominent axonal localization suggested a role for The analysis of the excision mutants allows us to con-
clude that loss of CYFIP induces lethality, which mostlythe CYFIP in axonogenesis. To test this hypothesis, we
generated CYFIP mutant flies. EP line (3)3267 harbors occurs during pupal life, the first morphological abnor-
malities being observed around 12 hours after pupariuma transposon on the right arm of the third chromosome,
at position 88F. The transposon is inserted within exon formation. Pupae progressively shrink within the pupar-
ium case before the head has everted (data not shown).1 of the CYFIP gene, in its 5-UTR (Figure 2A). Southern
blotting using an EP-specific probe on genomic DNA
isolated from EP(3)3267 and from wild-type (wt) flies CYFIP Is Required for Axonal Pathfinding
and Growthconfirmed the presence of a single transposon in the
EP line (data not shown). EP(3)3267 is a semiviable line, To characterize the effects of CYFIP loss, we labeled
mutant embryos with antibodies that recognize differentwith 50% of the homozygous animals dying before
eclosion. subsets and subcellular compartments of neurons in
the central and in the peripheral nervous system (CNSWe performed P element mutagenesis and recovered
111 independent excision lines. Eight lines are homozy- and PNS, respectively). The anti-Fas II antibody labels
motor axons as well as three central axon fascicles pergous lethal and show substantial loss of CYFIP immuno-
labeling. In contrast, all viable or semiviable lines do hemisegment (Figure 3A). A high percentage of CYFIP
embryos display abnormalities in axon guidance. In 79%express CYFIP, as assayed in Western blot from homo-
zygous adult extracts (data not shown). Breakpoints of the mutant embryos (n  150), axons abnormally
cross the midline. In most cases, midline crossing oc-were sequenced in three of the eight mutant lines
(CYFIP5.2, CYFIP8.1, CYFIP85.1) (Figure 2B and data not curs once or twice per embryo (Figure 3A, arrow); 13%
of the mutants show a more severe phenotype that in-shown). We also recovered and characterized three lines
(CYFIP70.1, CYFIP1.1, CYFIP35.1) that are 100% viable and cludes multiple midline crossings (Figure 3A″, arrows),
fasciculation defects, and interrupted fascicles (Figureconstitute precise excision events (Figure 2B and data
not shown). 3A″, arrowheads). Midline crossing was never observed
in wt embryos (number of embryos  100), nor in theCYFIP is located 250 bp downstream from a gene
(CG6226) (see Figure 2A) that codes for a putative pepti- precise excision CYFIP70.1 (n  150). Central axon label-
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Finally, using two driver copies further improved rescue,
with viability reaching 76% (n 150). In summary, CYFIP
plays a role in guidance and morphology of central and
peripheral axons.
CYFIP Regulates Synaptic Morphology at the NMJ
In humans, mice, and flies, lack of FMRP/dFMR1 results
in synaptic changes (Hinton et al., 1991; Comery et al.,
1997; Zhang et al., 2001). In Drosophila, the dFMR1
requirement for synapse development has been demon-
strated at the larval NMJ. dFMR1 deficiency results in
synapse overgrowth, while dFMR1 overexpression
leads to synapse undergrowth (Zhang et al., 2001). Be-
cause of these findings and since CYFIP localizes to
embryonic NMJ at the time synaptogenesis takes place,
we examined the structure of synaptic terminals in
CYFIP mutants. Third instar larva muscle 4 type 1b termi-
nal, one of simplest and most characterized terminals,
has been considered for this analysis.
NMJ appears contracted in CYFIP mutants compared
to wt (Figure 4A, panels 4Ac and 4Ad versus panels
4Aa and 4Ab). In the literature, the number of synaptic
boutons has usually been used to characterize the size
of synaptic terminals. In the case of CYFIP, this parame-
ter cannot be used; synaptic boutons appear fused or
Figure 3. CYFIP Is Required in Central and Peripheral Axons not well developed, which makes it difficult to identify
Panels (A)–(A″) show Fas II labeling. (A) wt embryo. (A and A″) and measure their size and number (Figure 4A, panels
CYFIP85.1 embryos showing midline crossing (arrows). In the most 4Ac and 4Ad and magnification in 4Ad). To statistically
severe case (A″), axons cross the midline several times, and longitu- evaluate the CYFIP phenotype, we defined a new param-
dinal connectives are not well separated (arrowheads).
eter: the total length of the synaptic terminal. In brief,Panels (B)–(B″) show BP102 labeling. (B) wt embryo. (B and B″)
NMJs were fluorescently labeled with synaptic markerCYFIP85.1 embryos. Connectives and commissures are thicker than
anti-DLG and analyzed by conventional microscopy.in wt (asterisks) and are not properly separated (arrowheads). (B″)
Break in the longitudinal connectives (arrow). Pictures were imported into an in-house developed soft-
Panels (C)–(C″) show Fas II labeling of motor neurons. Two abdomi- ware (NSURFX), which allowed us to automatically mea-
nal segments are shown. (C) wt embryo. (C and C″) CYFIP85.1 em- sure the length of the redrawn DLG-positive structure.
bryos showing intersegmental nerve defects: axon stalling (arrow)
In CYFIP larvae, synaptic length is reduced to 67%–and abnormal branching (asterisks). All images show stage 17 em-
70% compared to that found in wt or revertant (precisebryos.
excision) animals (71 versus 105 or 101 m, p  0.001),(A) and (B) panels: ventral views, anterior to the top; (C) panels:
lateral views, anterior to the left. Scale bar, 20 m. a phenotype that is completely rescued by elav-Gal4-
driven CYFIP expression (Figures 4B and 4C). A ten-
dency for reduced synaptic length is already observed
ing with monoclonal antibody BP102 (Figure 3B) re- in heterozygous CYFIP animals (p 0.05 versus wt, p
vealed thickening of connectives and commissures 0.1 versus revertants), a finding that suggests a dose-
(11% of mutant embryos, n 100) (Figures 3B and 3B″, dependent effect. We also measured the synaptic length
asterisks) and occasional connective breaks (Figure of dFMR1 null NMJs (Figure 4A, panels 4Ae and 4Af),
3B″, arrow). Finally, 10% of the mutant embryos show which show overgrowth, based on the number of bou-
defects in motor axons that could be classified as stall- tons (Zhang et al., 2001). dFMR1 larvae show a 20%
ing (Figure 3C, arrow) and abnormal branching, respec- length increase over wt controls (126 versus 105m, p
tively (Figures 3C and 3C″, asterisks) (n  100). 0.001) (Figure 4B), indicating that the two approaches
Similar CNS and PNS defects were found in transhet- (counting bouton number and measuring synaptic
erozygous embryos carrying large IIIR to Y chromosome length) produce similar results. Loss of CYFIP, therefore,
transpositions (segment 88–93) and the CYFIP null mu- has an opposite effect to loss of dFMR1 on synapse
tation (data not shown). Furthermore, to provide final growth.
evidence that the observed phenotypes are specifically A second striking feature of CYFIP NMJs is the occur-
due to loss of CYFIP, we generated UAS-CYFIP trans- rence of supernumerary buds (Figure 4A, panels 4Ac,
genic animals. A third chromosome UAS-CYFIP trans- 4Ad, and magnifications in 4Ac inset and 4Ad). Buds
gene was recombined into the CYFIP85.1 null background arising from preexisting boutons have been described
(UAS-CYFIP, CYFIP). CYFIP mutant animals carrying the as an intermediate structure toward establishment of a
panneuronal elav-Gal4 driver and the UAS-CYFIP trans- new bouton (Zito et al., 1999). Synaptic terminals in
gene showed rescue of the midline crossing phenotype CYFIP mutants exhibit about four to five times more
(79% crossing frequency in null embryos, 10% in res- buds than wt or revertant terminals (7.8 versus 1.6 or 2.0,
cued embryos; n  100). Moreover, early pupal lethality p 0.001) (Figure 4C). Thus, the CYFIP NMJ presents an
was completely rescued, and some animals reached overall immature aspect, likely due to a block in synapse
differentiation.adulthood (2%; number of expected adults, n  400).
CYFIP Links dFMR1 and dRac1 in Neuronal Wiring
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Figure 4. CYFIP Controls Synaptogenesis at
NMJ
(A) DLG immunolabeling of muscle 4 synaptic
terminals. Third instar larvae of the following
genotypes: (Aa, Ab, and Ab) wt, (Ac, Ad, and
Ad) CYFIP85.1, and (Ae, Af, and Af) dFMR1.
Compared to wt, CYFIP synapses display un-
dergrowth, disturbed bouton structure, and
supernumerary budding. dFMR1 synapses
display overgrowth. Insets in (Aa) and (Ac)
show high magnification of marked regions.
Arrowheads indicate buds. Panels (Ab),
(Ad), and (Af) are high magnifications of
marked regions in (Ab), (Ad), and (Af), respec-
tively. Scale bar, 20 m (Aa–Af), 3 m (Ab,
Ad, and Af).
(B and C) Statistic evaluation of NMJ pheno-
types of the following genotypes: wt,
CYFIP85.1 (CYFIP), CYFIP85.1 heterozygous
(CYFIP/), precise excision CYFIP70.1 (re-
vertant), elav-Gal4; UAS-CYFIP, CYFIP85.1
(rescue), and dFMR1. Sample size (number
of muscle 4 junctions scored) was 28 per
genotype. Error bars indicate SEM; statistical
significance was calculated using ANOVA
and the Newman-Keuls method for post hoc
pair-wise analyses. Significant differences
versus wt are indicated on top of bars (*p 
0.05; ***p  0.001).
(B) Length of synaptic terminals in microns,
as measured using NSURFX software (see
Experimental Procedures).
(C) Number of buds per synapse.
CYFIP Maternal Contribution Biochemical Interactions of CYFIP
with dFMR1 and dRac1Several observations call for a CYFIP maternal contribu-
tion. First, axon tracts from null embryos are still faintly Human CYFIP1 and CYFIP2 interact with FMRP (Schenck
et al., 2001). Independently, CYFIP1 has been reportedlabeled with the CYFIP antibody (Figure 5A). Second,
CYFIP RNA is highly expressed in ovaries (Figure 1A). as a target for the Rac1 small GTPase (Kobayashi et al.,
1998). In order to define the molecular role of DrosophilaThird, CYFIP RNA/protein are present very early during
embryogenesis (Figures 1B and 1D). To determine CYFIP, we asked whether the molecular interactions
with FMRP and Rac1 fly orthologs are conserved. Towhether CYFIP immunoreactivity in null embryos is of
maternal origin, we compared the content of CYFIP in test for dFMR1-CYFIP interaction in vitro, we used a
GST-dFMR1 fusion (Schenck et al., 2002). GST-dFMR1protein extracts from wt and CYFIP mutants [EP(3)3267
and CYFIP85.1 homozygous] at embryonic and larval stages. or GST alone was used in GST pull-down assays and
incubated with in vitro-translated, radiolabeled lucifer-Western blot analysis demonstrated that EP(3)3267 is a
hypomorphic allele that displays reduced CYFIP levels ase as negative control, or with CYFIP. For this purpose,
two largely overlapping CYFIP fragments were usedthroughout development (Figure 5B). CYFIP85.1, on the
other hand, shows faint levels of expression in embryos (Figure 6A, top). Both of them interact with GST-dFMR1
but not with GST alone (Figure 6A). Luciferase was nei-but not in wandering larvae, in agreement with the obser-
vation that maternal contribution is generally no longer ther bound by GST nor by GST-dFMR1. Next, to confirm
CYFIP-dFMR1 interaction, we immunoprecipitated en-detectable at that stage. Based on the amount of protein
present in null embryos, the amount of maternal contri- dogenous CYFIP from cytoplasmic extracts of S2 cells
transiently overexpressing dFMR1. dFMR1 coimmuno-bution corresponds to 10%–15% of CYFIP expression
in wt embryos (Figure 5B). precipitated with endogenous CYFIP. In contrast, no
dFMR1 was found when an aliquot of the same extractTo determine the importance of the maternal contribu-
tion, we used the FLP/ovoD system (Chou and Perrimon, was incubated with comparable amounts of rabbit IgG
(Figure 6B).1996) and generated homozygous CYFIP mutant clones
within the germline of heterozygous females. Deletion We also performed coimmunoprecipitation experi-
ments to check for dRac1-CYFIP interaction (Figure 6C).of both maternal and zygotic CYFIP leads to variable
but dramatically enhanced nervous system defects (Fig- We transfected S2 cells with flag-tagged dRac1 con-
structs carrying either the constitutively active mutationure 5C, compare with Figures 3A and 3A) and to embry-
onic lethality. These data indicate that the maternal con- V12 (dRac1V12) or the dominant-negative mutation N17
(dRac1N17) and precipitated the proteins via their flagtribution of CYFIP rescues nervous system defects and
embryonic lethality. tags. Endogenous CYFIP was found to coimmunopreci-
Neuron
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Figure 5. CYFIP Maternal Component
(A) CYFIP labeling in the ventral nerve cord of homozygous CYFIP85.1
embryos and heterozygous sibs at stage 17. Ventral views, anterior
to the top. Arrowheads indicate midline, where CYFIP is also ex-
pressed. Residual immunolabeling is observed in zygotic null em-
bryos.
(B) Western blot analysis in wild-type (wt), homozygous EP(3)3267 Figure 6. CYFIP Interacts In Vitro and In Vivo with dFMR1 and dRac1
(EP), homozygous CYFIP85.1 embryos (CYFIP) (stage 12–17), and in (A) Pull-down assay between GST-tagged dFMR1 and in vitro-trans-
wandering L3 larvae of the same genotypes. The same blots were lated CYFIP fragments or between GST-dFMR1 and luciferase (con-
probed with anti--tubulin to show equivalent protein loading. trol) in the presence of 150 mM NaCl. CYFIP-N and CYFIP-C indicate
(C) Fas II labeling of an embryo devoid of maternal and zygotic two overlapping framents carrying the N- (aa 1–1152) and the
CYFIP components (CYFIP mz), revealing strongly disturbed CNS C-terminal part (aa 167–1291) of CYFIP, respectively. In the Input
development (compare with wt and CYFIP zygotic mutant embryos, lanes, 25% of the translation products used in a reaction were
Figure 3, panels 3A–3A″). loaded. CYFIP but not luciferase interacts with dFMR1. None of
(A–C) Scale bars, 20 m. them unspecifically interact with GST alone.
(B) Western blot showing interaction between endogenous CYFIP
and transiently overexpressed dFMR1 in S2 cells. Material loaded
is indicated on top of each lane (anti-CYFIP IP, extract anti-CYFIP;pitate with dRac1V12 but not with dRac1N17. No CYFIP
IgG IP, extract rabbit IgG), proteins revealed by Western blot to thewas found in a control anti-flag precipitation using an
right of each panel. Anti-CYFIP but not IgG coimmunoprecipitatesequal amount of nontransfected extract. Therefore,
dFMR1 (comparable amounts of antibodies were used). Anti-dFMR1
CYFIP interacts with dRac1 in an activity-dependent reveals two bands at 85 and 92 kD, as described in Schenck et al.
manner. In the same experiment, endogenous dFMR1 (2002).
was not found to coimmunoprecipitate with dRac1V12 (C) Anti-flag coimmunoprecipitation experiments revealing activity-
dependent interaction between overexpressed dRac1 and endoge-and CYFIP (data not shown). CYFIP may thus be present
nous CYFIP. As in (B), loaded material is indicated on top of eachin two alternative complexes, associated with either
lane, proteins revealed by Western blot to the right of each panel.dFMR1 or with dRac1. Small GTPases are thought to act
CYFIP specifically coimmunoprecipitates with flag-dRac1V12 (lane
by modifying the conformation of their effector proteins, in the middle) but not with flag-dRac1N17 (lane to the left).
which are normally bound by the GTPases in their active
state (Bishop and Hall, 2000). The activity-dependent
interaction with dRac1 suggests that CYFIP represents
Cooverexpression of dRac1V12 and CYFIP partially res-
such a Rac1 effector protein.
cued the two phenotypes (Figure 7E, asterisk), while
cooverexpression of an unrelated protein, -gal, had
no effect on the dRac1V12 phenotype. The observedCYFIP Antagonizes dRac1 and dFMR1 in the Eye
To gain insights into the signaling cascade involving antagonistic interaction between dRac1 and CYFIP was
subsequently confirmed by using a sensitized back-dRac1, CYFIP, and dFMR1, we performed genetic inter-
action experiments. Since unbalance between gene ground. dRac1V12 overexpression in flies that carry only
half a dose of CYFIP show a much stronger phenotypeproducts that work in the same pathway often induces
a mutant phenotype, we overexpressed the three genes compared to that observed in wt flies overexpressing
dRac1V12 (Figure 7F, asterisk). Eyes are strongly re-in the eye using the GMR-Gal4 driver. No effect on eye
morphology upon CYFIP overexpression could be de- duced in size and flattened. The entire posterior half of
these eyes has lost ommatidia and is deformed; omma-tected (Figure 7B). Overexpression of dRac1V12, on the
other hand, caused a mild rough phenotype, indicative tidia in the rest of the eye are not distinct from each
other. In summary, CYFIP overexpression suppressesof ommatidia misorganization, and complete loss of om-
matidia in the posterior region (Figure 7D, asterisk). the rough eye phenotype due to overexpression of con-
CYFIP Links dFMR1 and dRac1 in Neuronal Wiring
893
flies carrying UAS-dRac1N17, the dominant-negative
form of dRac1. As reported by Chang and Ready (2000),
eye overexpression of dRac1N17 also induces a rough
eye phenotype. Indeed, constitutively active and domi-
nant-negative small GTPase mutants often produce sim-
ilar rather than opposite phenotypes, as expected from
molecules that have a cyclic mode of action (Luo, 2000).
In contrast to the strong interactions observed with the
activated form of dRac1, we did not detect an influence
of CYFIP dosage in this analysis (Figures 7G–7I). The
finding that overexpression of CYFIP cannot rescue the
dRac1N17 overexpression phenotype is likely due to the
inability of dRac1N17 to bind (see above) and activate its
effector CYFIP.
Overexpression of dFMR1 affects eye morphology
(sevenless-Gal4; Wan et al., 2000; Zhang et al., 2001)
(GMR-Gal4; Figure 7J). Overexpression of CYFIP par-
tially rescues ommatidia misorganization caused by
dFMR1 overexpression (Figure 7K). In contrast, dFMR1
overexpression in heterozygous CYFIP flies results in
an enhanced phenotype: eyes are of reduced size and
contain areas lacking distinct ommatidia (Figure 7L).
This led us to conclude that, like CYFIP and dRac1,
CYFIP and dFMR1 stand in an antagonistic relationship,
in perfect agreement with the opposite effects of dFMR1
and CYFIP loss on synapse morphology.
To further characterize the relationship among the
three players, we also asked whether dRac1 and dFMR1
genetically interact. For this purpose, we overexpressed
dFMR1 in genetic backgrounds of either elevated or
reduced dRac1 levels. The latter was achieved by using
a deficiency, Df(3L)Ar14-8, that uncovers dRac1 (Hu et
al., 2001). Cooverexpressing dFMR1 and dRac1 has a
more severe phenotype than overexpressing either of
the two proteins (Figure 7M versus 7D and 7J). Eyes
overexpressing dRac1 and dFMR1 appear narrowed
and show large ommatidia that are reduced in number
compared to wt. We also observed areas containing
degenerating ommatidia. On the other hand, overex-
pressing dFMR1 in eyes that have half a dose of dRac1
partially rescues the mutant phenotypes observed in
eyes that are wild-type for dRac1 and that overexpress
dFMR1 (Figure 7N versus 7J).
In summary, the eye phenotype of flies overexpress-
Figure 7. dRac1, CYFIP, and dFMR1 Dosage-Dependent Interac- ing dFMR1 is enhanced by dRac1 overexpression and
tions In Vivo suppressed by reduced dRac1 expression.
On top of each eye, overexpressed proteins are indicated by “”,
reduced protein levels by “	”. (A) Wild-type (wt). (B, D–O) GMR-
CYFIP Antagonizes dRac1 and dFMR1Gal4 driven expression. (B) UAS-CYFIP/TM3, (C) CYFIP/, (D) UAS-
in the Nervous SystemRac1V12/TM3, (E) UAS-Rac1V12/UAS-CYFIP, (F) UAS-Rac1V12/
CYFIP, (G) UAS-Rac1N17/, (H) UAS-Rac1N17/UAS-CYFIP, (I) UAS- To test whether the antagonistic dRac1-CYFIP and
Rac1N17/CYFIP, (J) UAS-dFMR1/TM3, (K) UAS-dFMR1/UAS- CYFIP-dFMR1 interactions reflect the general mode of
CYFIP, (L) UAS-dFMR1/CYFIP, (M) UAS-dFMR1/UAS-Rac1V12, (N) action of these molecules, we performed gene dosage
UAS-dFMR1/Df(3L)Ar14-8. Asterisk in panel (D) marks the posterior
experiments in the nervous system and confirmed ourregion of the dRac1V12 overexpressing eye, which has lost omma-
finding of CYFIP antagonizing dRac1 and dFMR1 (Tabletidia structure. Asterisks in panels (E) and (F) mark the corresponding
1). In this case, elav-Gal4 was used as a driver.region in eyes with elevated or reduced levels of CYFIP. UAS-CYFIP
and UAS-dFMR1 indicate EP-lines EP(3)3267 and EP(3)3517, re- To investigate the effect of CYFIP dosage on neuronal
spectively. For all genotypes, male eyes of representative phenotype dRac1V12 overexpression, we scored for the premature
are shown. All flies were maintained at 25C. (O) Model for dRac1, arrest phenotype of intersegmental motor nerve b (ISNb),
CYFIP, and dFMR1 signaling pathway.
which has been previously reported for dRac1V12 (Kauf-
mann et al., 1998). In elav-dRac1V12 embryos, 29% of
ISNb were arrested at the site of contact with ventralstitutively active Rac1, while loss of one dose of CYFIP
enhances that phenotype. longitudinal muscle 13 before reaching their final target,
muscle 12 (see Table 1, schematic illustration) (27%The same CYFIP allelic combinations were used with
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Table 1. Genetic Interactions in the Nervous System
A. dRac1V12-CYFIP in Axonogenesis
dRac1V12 dRac1V12CYFIP dRac1V12 	1/2CYFIP
Aberrant midline crossing 0% 0% 8%
(n  135) (n  90) (n  105)
ISNb premature arrest
71% 83% 40%normal growth
partial arrest 27% 16% 53%
complete arrest 2% 1% 7%
(n  348) (n  244) (n  307)
B. CYFIP-dFMR1 at the NMJ
dFMR1 dFMR1 CYFIP dFMR1 	1/2CYFIP
Synaptic terminal length (wt  105 
 3 m) 70 
 4 m 89 
 5 m 65 
 3 m
(n  28) (n  28) (n 28)
Aberrant midline crossing: n  number of embryos scored. % indicates percentage of embryos showing at least one ectopic midline crossing
of FasII-labeled fascicles.
ISNb premature arrest: n  number of embryonic stage 17 abdominal hemisegments A2-A7 scored. Wt ISNb nerves extend to contact distal
muscle 12 (see schematic drawing). Complete arrest indicates ISNb nerves that completely stop at the site of contact with muscle 13 ( ).
Partial arrest indicates cases in which at least 50% of ISNb motor fibers stop at the site of contact with muscle 13. See Supplemental Data
online.
Synaptic terminal length has been determined as in Figure 4 and is indicated 
 SD. n  number of muscle 4 synapses scored.
Genotypes are according to Figure 7, using elav-Gal4 as a driver.
partial 2% complete arrest). Cooverexpressing CYFIP Discussion
reduced the frequency of the dRac1V12 arrest pheno-
Neuronal morphogenesis and connectivity require actintype to 17% (16%  1%; p  0.05; X2 versus
cytoskeleton remodeling as well as local translation indRac1V12). Accordingly, reducing CYFIP dosage
response to extracellular signals (reviewed in Luo, 2002;strongly increased it: partial ISNb stalling reaches 53%,
Steward and Schuman, 2001). Synaptic plasticity, acomplete stalling, 7% (p 0.001; X2 versusdRac1V12).
mechanism of information storage in learning and mem-Additional striking evidence for genetic interaction
ory, also involves these processes (Martin et al., 2000).between dRac1V12 and CYFIP in the nervous system
Here we present data indicating that the CYFIP adaptorcame from the analysis of central axons. Neither em-
molecule directly interacts with two classes of proteinsbryos overexpressing dRac1V12 nor heterozygous
that are involved in such processes. Understanding theCYFIP null embryos ever showed ectopic midline cross-
molecular link between cytoskeleton reorganization anding, whereas 8% of embryos overexpressing dRac1V12
local control of translation is an important topic, as itin heterozygous CYFIP background showed these axon
will help us to elucidate the molecular bases of neuronalguidance errors (Table 1A). Thus, as in the eye, CYFIP
plasticity and learning.antagonizes activated dRac1 in motor axon outgrowth
and in pathfinding at the midline choice point.
One of the most striking dFMR1 phenotypes observed CYFIP: The Missing Link
during nervous system differentiation concerns the neu- Mutations in Rho GTPases, which control cytoskeleton
romuscular junction (Zhang et al., 2001). Neuronal reorganization, affect wiring in neuronal cell systems
dFMR1 overexpression causes synaptic undergrowth, and animal models (reviewed in Luo, 2002). Moreover,
as visualized by the reduced average synaptic length: defects in their pathways are associated with mental
105 m in wt (see above) and 70 m upon dFMR1 over- retardation in humans (reviewed in Ramakers, 2002;
expression (dFMR1; p  0.001 versus wt; ANOVA) Chelly and Mandel, 2001; Luo, 2000) and with altered
(Table 1). While cooverexpression of a control (-gal) dendritic spines in animal models (Meng et al., 2002;
had no effect on the dFMR1 overexpression phenotype Luo et al., 1996) and cultured rat hippocampal slices
(data not shown), cooverexpression of CYFIP rescued (Nakayama et al., 2000).
synapse length to an average of 89 m (dFMR1  A growing body of evidence indicates that local pro-
CYFIP; p  0.001 versus dFMR1; ANOVA). Finally, de- tein synthesis is a key feature of synaptic plasticity (re-
creasing CYFIP dosage in the dFMR1 overexpressing viewed in Steward and Schuman, 2001). All the machin-
synapses showed the tendency to further reduce synap- ery necessary for protein synthesis is present at the
tic length (dFMR1-1/2CYFIP; p 0.5 versusdFMR1; site of synaptic contact (Steward and Levy, 1982). In
ANOVA), altogether suggesting that the antagonistic re- addition, local protein synthesis occurs in live tran-
lation between CYFIP and dFMR1 is also conserved in sected dendrites (Torre and Steward, 1992). It has been
recently proposed that FMRP, the protein absent in frag-the nervous system.
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ile X mental retardation syndrome, and its Drosophila apse growth. Loss of dFMR1 (Zhang et al., 2001) there-
fore produces a NMJ phenotype that is opposite to thatortholog regulate translation (Laggerbauer et al., 2001;
of CYFIP null flies. Our in vivo data support the ideaLi et al., 2001; Brown et al., 2001; Zhang et al., 2001),
that Rac1 is involved in the formation of synaptic motorin particular at the synapse (Greenough et al., 2001;
terminals. In the future, the analyses of loss of functionZalfa et al., 2003; Miyashiro et al., 2003). FMRP is indeed
mutations will clarify the role of Rho GTPases at theassociated with polyribosomes (Corbin et al., 1997; Feng
synapse.et al., 1997), its synthesis being increased in response
In addition to the synapse, CYFIP mutations affectto neurotransmitter activation in distal dendrites (Weiler
other aspects of neuronal morphogenesis: axonal path-et al., 1997). All these results call for a role of FMRP in
finding (midline crossing), growth (motor axon stalling),the control of local protein synthesis underlying synaptic
and branching (ectopic motor axon branching). Defectsplasticity (Greenough et al., 2001).
in these processes are also shared by dRac1 and dFMR1Loss of FMRP in human patients and in the fragile X
mutants (Kaufmann et al., 1998; Ng et al., 2002; Hakeda-mouse model causes synaptic abnormalities (changed
Suzuki et al., 2002; Morales et al., 2002; Dockendorff etnumber and shape of dendritic spines) (Comery et al.,
al., 2002), which further supports the idea that Drosoph-1997; Irwin et al., 2000) strikingly resembling those ob-
ila Rac1, CYFIP, and dFMR1 work in the same pathway.served in mutants affecting Rac1 signaling pathways.
Gene dosage experiments in the eye and in the nervousThe convergent phenotypes of mutations affecting
system suggest a negative regulation between dRac1FMRP and Rho GTPase pathways suggest a molecular
and CYFIP as well as between CYFIP and dFMR1, whichlink in neuronal remodeling. Moreover, FMRP interacting
results in an agonistic relationship between dRac1 andprotein CYFIP1 (Schenck et al., 2001) has been shown
dFMR1. Based on biochemical and genetic data, weto interact with Rac1 (Kobayashi et al., 1998). Here we
therefore propose a model (Figure 7O) in which dRac1provide biochemical and genetic evidence that CYFIP,
activation upon unknown extracellular signals positivelythe fly ortholog, interacts with dRac1 and dFMR1, thus
regulates dFMR1 action on neuronal morphogenesis.establishing in vivo that these molecules act in a com-
Interestingly, the frequency of axonal defects ob-mon pathway. Lack of motifs typical of proteins that
served in CYFIP embryos seems lower compared to thatregulate Rho GTPase activity, such as GTPase activat-
found in Drosophila Rac mutants (Hakeda-Suzuki et al.,ing proteins (GAPs) (Scheffzek et al., 1998) and guanine
2002). Moreover, axons abnormally crossing the mid-nucleotide exchange factors (GEFs) (Schmidt and Hall,
line were observed in CYFIP and Rac mutants (Hakeda-2002), makes it unlikely that CYFIP acts upstream of
Suzuki et al., 2002) but not in dFMR1 mutants (datadRac1. In addition, the activity-dependent interaction
not shown). There are several non-mutually exclusivesuggests that CYFIP acts as a dRac1 effector. Indeed,
explanations for such differences. First, distinct extra-Rho GTPases only bind and transduce their signals to
cellular cues activate a Rho GTPase differentially in timedownstream targets once in the activated GTP-bound
and space, which may engage several downstream ef-state.
fector pathways. Lack of CYFIP may affect some of theIt is very likely that in vertebrates, too, FMRP and the
pathways activated by dRac1. Similarly, mutations in theRac1 pathway, both implicated in cognitive functions,
Rho GTPase GEF Trio and in its regulator, the receptorare connected through CYFIP proteins. Indeed, mouse/
tyrosine phosphatase Dlar, do not show identical axonalhuman CYFIP1 (Koster et al., 1998; Schenck et al., 2001),
phenotypes (Newsome et al., 2000; Bateman et al., 2000;FMRP (Agulhon et al., 1999; Weiler et al., 1997), and
Krueger et al., 1996). The cell-specific requirement ofRac1 (Hall, 1994; Nakayama et al., 2000) are widely ex-
gene interaction may also reflect differences in the pro-pressed in the developing as well as in the adult nervous
file of expression; while CYFIP accumulates in specificsystem and are present at synapses. All three proteins
axonal tracts and at synapses, dFMR1 seems to be more
share strong expression in the hippocampus, known for
widely distributed (Wan et al., 2000; Zhang et al., 2001).
its role in learning and memory. CYFIP2 is also present
Second, part of the null phenotypes may be hidden by
at synapses (Schenck et al., 2001). Understanding the the presence of RNA and/or protein loaded into the egg,
role of CYFIP1 and CYFIP2 in mammals awaits the char- as shown in the case of CYFIP. Indeed, dFMR1 has been
acterization of single and/or double mouse knockout reported to be expressed maternally (Wan et al., 2000;
phenotypes or the identification of mental retardation Schenck et al., 2002). The maternal requirement of
syndromes associated with CYFIP1/2 mutations. dRac1 and dFMR1 remains to be assessed.
Together with the data obtained in dFMR1 flies, our
CYFIP Controls Synaptogenesis results raise the question as to whether axons also show
and Axonogenesis abnormalities in fragile X syndrome. So far, this has
Consistent with the CYFIP expression profile, mutants not been reported in patients nor in the mouse FMRP
show defects at the neuromuscular junction. Drosophila knockout model; however, an implication of this protein
NMJs share a number of features with central excitatory in axonogenesis could be hidden by the presence of
synapses in the vertebrate brain and constitute the syn- FMRP-related FXR1 and FXR2 proteins. Indeed, FXR2P
aptic plasticity model in Drosophila (reviewed in Koh et is expressed in a pattern very similar to that of FMRP
al., 2000). In vivo studies on fly NMJ have shown that (Bakker et al., 2000; Agulhon et al., 1999), and some
new synaptic boutons are added by the budding of pre- behavioral phenotypes in the FXR2 knockout mice re-
existing ones (Zito et al., 1999). In CYFIP mutants, syn- semble those observed in FMR1 null mice (Bontekoe et
apse terminals are shorter and display a higher number al., 2002). Moreover, detection of subtle defects may
require a detailed analysis. Defects might be specificof buds than in wt animals, indicative of impaired syn-
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gen). For Western blot on S2 extract, the cell pellet was lysed in 1to axonal subsets, as has been shown in dFMR1 flies
SDS-PAGE loading buffer and subjected to SDS-PAGE analysis. For(Morales et al., 2002; Dockendorff et al., 2002).
embryonic and larval extracts, nonfixed animals (without or afterThe promiscuity of neuronal defects observed in the
X-gal staining) were mashed with a pestle in 150 mM NaCl, 20 mM
CYFIP mutants suggests a general role of the protein Tris-HCl (pH 7.5), 1 mM EDTA, 0.1 mM MgCl2, 1% Triton X-100, and
in actin cytoskeleton reorganization via Rho GTPase protease inhibitor cocktail (PIC). The supernatant of a 12,000  g
pathways. Such a role is in agreement with the associa- centrifugation was briefly sonicated, and the amount of total protein
was determined by Bradford assay.tion of CYFIP molecules with Rac1 (Kobayashi et al.
[1998] and the present study) and with CYFIP1 cosedi-
menting with actin in vitro (Kobayashi et al., 1998). It is In Situ Hybridization, Immunolabeling,
generally thought that Rac activation promotes neurite and Western Blot Analysis
In situ hybridization using digoxigenin-labeled riboprobes and im-extension, and it has been recently shown that WAVE1-
munolabeling was performed according to standard procedures.induced actin nucleation depends on Rac1 (Eden et al.,
CYFIP-specific riboprobes were generated from EST clone2002). The WAVE1 protein forms an inactive complex
LD47929. For CG6226-specific in situ hybridization, a riboprobe wasalso containing the CYFIP2 protein (also called PIR121),
generated from EST-clone LD33762. A peptide in the central region
which dissociates upon interaction with activated Rac1 of CYFIP was used for rabbit immunization and affinity purification of
(Eden et al., 2002). The dissociation into subcomplexes polyclonal anti-CYFIP antibody #1719 (used at 1:100). Other primary
releases activated WAVE1, which in turn stimulates actin antibodies were anti-Fas II (1:50) (gift of C. Goodman), anti-DLG
(1:400) (gift of P. Bryant), BP102 (1:100), 22C10 (1:20) (DSHB), anti-nucleation (Eden et al., 2002). We speculate that, simul-
-gal (1:500) (Sigma, Cappel), and anti--tubulin (Chemicon)taneously, CYFIP may be released to regulate dFMR1/
(1:4000). Secondary antibodies (Jackson) coupled with Cy3 or FITCFMRP-mediated translational control. Hence, CYFIP
were used at 1:400, HRP conjugated antibodies at 1:10,000. For
may be a protein factor at the crossroads between con- evaluation of NMJs, larvae open-book preparations were performed
trol of actin cytoskeleton and control of local protein as described in Bellen and Budnik (2000). Pictures of all synapses
translation in neurons. In the future, it will be important were imported in the in-house developed NSURFX software that
quantified the synaptic length by automatic measurement of theto dissect the dRac1 pathways in which CYFIP and
redrawn synaptic terminals.dFMR1 are involved and to understand the implication
of these pathways in the cognitive defects of fragile X
syndrome. Biochemical Interaction Assays
For immunoprecipitations, cytoplasmic extracts were prepared by
Experimental Procedures lysing S2 cells in buffer (300 mM NaCl, 20 mM Tris-HCl [pH 7.5], 5
mM MgCl2, 0.4% Triton X-100, PIC). The supernatant of a 2000 
Genetics g centrifugation was incubated with appropriate antibodies and pro-
The wild-type strain was Sevelen. Transposon insertion lines tein A Sepharose. Anti-flag-dRac1 V12 and N17 immunoprecipita-
EP(3)3267 and EP(3)3517 (Rorth, 1996) were provided by the Szeged tions were performed using extracts expressing the two mutant
Stock Center. GMR-Gal4 (ninaE.GMR-Gal4), elav-Gal4 (C155), proteins at a similar level and using beads covalently linked to anti-
Df(3L)Ar14-8, Df(3R)ea, Tp(3;Y)B150, and Tp(3;Y)L58 were obtained flag antibody M2 (Sigma). Beads were washed extensively in lysis
from the Berkeley Stock Center. UAS-dRac1V12 and UAS- buffer, boiled in SDS-PAGE loading buffer, and subjected to SDS-
dRac1N17 flies (Luo et al., 1994) were provided by D. Ready, and PAGE analysis. The GST-dFMR1 pull-down assay has been pre-
dFMR1 null strain 113M (Zhang et al., 2001; Morales et al., 2002) viously described (Schenck et al., 2002).
by B. Hassan. CYFIP mutants were obtained upon P element mobili-
zation in EP(3)3267 after isogenization. Excision lines were charac-
Microscopyterized by PCR. Transgenic lines were obtained using standard pro-
The confocal microscope was a Leica TCS4D. Fluorescence imagestocols. FRT82B and UAS-CYFIP (line 12.2) were recombined onto
in one focal plane were obtained using a Zeiss Axiophot2 micro-the CYFIP85.1 chromosome. Germline clones were induced in hs-
scope. Images of Drosophila eyes were taken on a Leica Mac-FLP; FRT82B ovoD/FRT82B CYFIP85.1 flies as described (Chou and
roscope M420 at seven focal planes and assembled using an in-Perrimon, 1996).
house developed software.
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